Why participate?
Understand the key stages of the antibody development cycle. Learn about the tools used to modulate the activity of therapeutic antibodies.
Training Context:
In 2024, 275 therapeutic antibodies are widely used in clinical practice, with the majority being used in oncology, and over 6,000 are currently in development. Among the biopharmaceuticals being developed by biotechnology and pharmaceutical companies, antibodies represent the majority. Since 1986, when the first monoclonal antibody was approved for marketing, knowledge in this field has continued to expand.
Interactive Teaching, Case Studies, Experience Sharing
Business developer, application engineer, research engineer, technician, researcher, manager, from service companies or biotechnology firms
Have a basic knowledge of biology or have completed the “Fundamentals of Biology and Biotechnology” training
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
